Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis (Q34182672)

31 July 2017

title

Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis (English)

1 reference

primary sclerosing cholangitis

31 July 2017

main subject

ascending cholangitis

0 references

1 reference

primary biliary cholangitis

inferred from title

0 references

author name string

Cynthia Levy

series ordinal

1

1 reference

31 July 2017

Keith D. Lindor

series ordinal

2

1 reference

31 July 2017

publication date

1 April 2003

1 reference

Current treatment options in gastroenterology

31 July 2017

published in

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

93-103

1 reference

Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007/S11938-003-0010-0

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

21 January 2018

1 reference

12 December 2020

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

1 reference

12 December 2020

Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial

1 reference

12 December 2020

Etiology and natural history of primary sclerosing cholangitis

1 reference

12 December 2020

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

1 reference

12 December 2020

Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid

1 reference

12 December 2020

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression

1 reference

12 December 2020

Epidemiology and natural history of primary biliary cirrhosis in a US community

1 reference

12 December 2020

Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.

1 reference

12 December 2020

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

1 reference

12 December 2020

Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy

1 reference

12 December 2020

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment

1 reference

12 December 2020

Cholangiocarcinoma complicating primary sclerosing cholangitis

1 reference

12 December 2020

Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study

1 reference

12 December 2020

Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis

1 reference

12 December 2020

Immunopathogenesis of primary biliary cirrhosis

1 reference

12 December 2020

The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

1 reference

12 December 2020

Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study

1 reference

12 December 2020

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

1 reference

12 December 2020

Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol

1 reference

12 December 2020

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry

1 reference

12 December 2020

Effects of Clofibrate in Primary Biliary Cirrhosis Hypercholesterolemia and Gallstones

1 reference

12 December 2020

Ursodeoxycholic Acid Delays the Onset of Esophageal Varices in Primary Biliary Cirrhosis

1 reference

12 December 2020

Primary sclerosing cholangitis: liver transplantation or biliary surgery

1 reference

12 December 2020

Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy

1 reference

12 December 2020

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone

1 reference

12 December 2020

Randomized pilot trial of vitamin K2 for bone loss in patients with primary biliary cirrhosis.

1 reference

12 December 2020

Fat-soluble vitamin levels in patients with primary biliary cirrhosis

1 reference

12 December 2020

Recurrence of primary sclerosing cholangitis after liver transplantation

1 reference

12 December 2020

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers

1 reference

12 December 2020

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis

1 reference

12 December 2020

Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?

1 reference

12 December 2020

Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis

1 reference

12 December 2020

Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study

1 reference

12 December 2020

Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

12 December 2020

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial

1 reference

12 December 2020

Surgical treatment for primary sclerosing cholangitis

1 reference

12 December 2020

Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial

1 reference

12 December 2020

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis

1 reference

12 December 2020

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future

1 reference

12 December 2020

Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation

1 reference

12 December 2020

Paradoxical Elevation of Serum Cholesterol by Clofibrate in Patients with Primary Biliary Cirrhosis

1 reference

12 December 2020

The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

12 December 2020

Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis

1 reference

12 December 2020

Primary sclerosing cholangitis: surgical options, prognostic variables and outcome

1 reference

12 December 2020

Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron

1 reference

12 December 2020

Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis

1 reference

12 December 2020

Risk factors for primary biliary cirrhosis in a cohort of patients from the united states

1 reference

12 December 2020

Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis

1 reference

12 December 2020

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

12 December 2020

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

12 December 2020

The pathogenesis and treatment of pruritus and fatigue in patients with PBC.

1 reference

12 December 2020

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

1 reference

12 December 2020

Endoscopic therapy of sclerosing cholangitis

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

The demography of primary biliary cirrhosis in Ontario, Canada

1 reference

12 December 2020

Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.

1 reference

12 December 2020

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

1 reference

12 December 2020

Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?

1 reference

12 December 2020

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

1 reference

12 December 2020

A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver

1 reference

12 December 2020

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

12 December 2020

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression

1 reference

12 December 2020

Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer

1 reference

12 December 2020

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron

1 reference

12 December 2020

Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

1 reference

12 December 2020

10.1007/S11938-003-0010-0

Identifiers

DOI

1 reference

31 July 2017

1 reference